Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-label, Phase 1a Study of HC-5404-FU in Subjects With Advanced Solid Tumors

NCT04834778 is registered in ClinicalTrials.gov with HiberCell, Inc. as lead sponsor.

NCT NCT04834778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04834778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-label, Phase 1a Study of HC-5404-FU in Subjects With Advanced Solid Tumors
Lead sponsor
HiberCell, Inc.
Phase
Phase 1
Overall status
Completed
Start date
June 8, 2021
Completion date
January 30, 2024
Enrollment
23 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, metastatic breast cancer, other solid tumors, renal cell carcinoma, small-cell lung cancer